Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer

被引:91
作者
Buisseret, Laurence [1 ,2 ,3 ]
Desmedt, Christine [2 ]
Garaud, Soizic [1 ]
Fornili, Marco [4 ]
Wang, Xiaoxiao [1 ,2 ,3 ]
Van den Eyden, Gert [5 ]
de Wind, Alexandre [6 ]
Duquenne, Sebastien [6 ,8 ]
Boisson, Anais [1 ]
Naveaux, Celine [1 ]
Rothe, Francoise [2 ]
Rorive, Sandrine [7 ]
Decaestecker, Christine [7 ]
Larsimont, Denis [6 ]
Piccart-Gebhart, Martine [3 ]
Biganzoli, Elia [4 ]
Sotiriou, Christos [2 ,3 ]
Willard-Gallo, Karen [1 ]
机构
[1] Univ Libre Bruxelles, Inst Jules Bordet, Mol Immunol Unit, 121 Blvd Waterloo, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium
[3] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Brussels, Belgium
[4] Univ Milan, Dept Clin Sci & Community Hlth, Unit Med Stat Biometry & Bioinformat Giulio A Mac, Fdn IRCCS Ist Nazl Tumori, Campus Cascina Rosa, Milan, Italy
[5] GZA Ziekenhuizen, Dept Pathol, Sint Augustinus Campus, Antwerp, Belgium
[6] Univ Libre Bruxelles, Inst Jules Bordet, Dept Pathol, Brussels, Belgium
[7] Ctr Microscopy & Mol Imaging, Gosselies, Belgium
[8] Ctr Hosp Univ la Reunion, Dept Pathol, St Pierre, Reunion, France
关键词
PROGNOSTIC-SIGNIFICANCE; CHEMOTHERAPY; AGREEMENT;
D O I
10.1038/modpathol.2017.43
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The presence of tumor-infiltrating lymphocytes (TIL), reflecting host immune activity, is frequently correlated with better clinical outcomes, particularly in HER2-positive and triple-negative breast cancer. Recent findings suggest that organization of immune infiltrates in tertiary lymphoid structures also has a beneficial effect on survival. This study investigated inter-and intra-observer variation in TIL assessment using conventional hematoxylin-eosin versus immunohistochemical staining to identify immune cells. Global, intratumoral, and stromal TIL, as well as tertiary lymphoid structures were scored independently by experienced pathologists on full-face tumor sections (n = 124). The fidelity of scoring infiltrates in core biopsies compared to surgical specimens, and pathological assessment compared to quantitative digital analysis was also evaluated. The inter-observer concordance correlation coefficient was 0.80 for global, 0.72 for intratumoral, and 0.71 for stromal TIL, while the intra-observer concordance correlation coefficient was 0.90 for global, 0.77 for intratumoral, and 0.89 for stromal TIL using immunohistochemical stains. Correlations were lower with hematoxylin-eosin stains, particularly for intratumoral TIL, while global scores had the highest concordance correlation coefficients. Our study concluded that tertiary lymphoid structures are accurately and consistently scored using immunohistochemical but not hematoxylin-eosin stains. A strong association was observed between TIL in core biopsies and surgical samples (R-2 = 0.74) but this did not extend to tertiary lymphoid structures (R-2 = 0.26). TIL scored by pathologists and digital analysis were correlated but our analysis reveals a constant bias between these methods. These data challenge current criteria for TIL and tertiary lymphoid structure assessment in breast cancer and recommend that how pathologists evaluate immune infiltrates be reexamined for future studies.
引用
收藏
页码:1204 / 1212
页数:9
相关论文
共 24 条
  • [11] Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients
    Figenschau, Stine L.
    Fismen, Silje
    Fenton, Kristin A.
    Fenton, Christopher
    Mortensen, Elin S.
    [J]. BMC CANCER, 2015, 15
  • [12] GRUOSSO T, 2017, CANCER RES, V77
  • [13] CD4+ follicular helper T cell infiltration predicts breast cancer survival
    Gu-Trantien, Chunyan
    Loi, Sherene
    Garaud, Soizic
    Equeter, Carole
    Libin, Myriam
    de Wind, Alexandre
    Ravoet, Marie
    Le Buanec, Helene
    Sibille, Catherine
    Manfouo-Foutsop, Germain
    Veys, Isabelle
    Haibe-Kains, Benjamin
    Singhal, Sandeep K.
    Michiels, Stefan
    Rothe, Francoise
    Salgado, Roberto
    Duvillier, Hugues
    Ignatiadis, Michail
    Desmedt, Christine
    Bron, Dominique
    Larsimont, Denis
    Piccart, Martine
    Sotiriou, Christos
    Willard-Gallo, Karen
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07) : 2873 - 2892
  • [14] A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue
    Laurinavicius, Arvydas
    Plancoulaine, Benoit
    Laurinaviciene, Aida
    Herlin, Paulette
    Meskauskas, Raimundas
    Baltrusaityte, Indra
    Besusparis, Justinas
    Dasevicius, Darius
    Elie, Nicolas
    Iqbal, Yasir
    Bor, Catherine
    Ellis, Ian O.
    [J]. BREAST CANCER RESEARCH, 2014, 16 (02)
  • [15] Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
    Lee, Hee Jin
    Park, In Ah
    Song, In Hye
    Shin, Su-Jin
    Kim, Joo Young
    Yu, Jong Han
    Gong, Gyungyub
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (05) : 422 - 430
  • [16] Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab
    Lee, Hee Jin
    Kim, Joo Young
    Park, In Ah
    Song, In Hye
    Yu, Jong Han
    Ahn, Jin-Hee
    Gong, Gyungyub
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 278 - 288
  • [17] Lin L, 2012, STATISTICAL TOOLS FOR MEASURING AGREEMENT, P1, DOI 10.1007/978-1-4614-0562-7
  • [18] Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
    Loi, S.
    Michiels, S.
    Salgado, R.
    Sirtaine, N.
    Jose, V.
    Fumagalli, D.
    Kellokumpu-Lehtinen, P-L
    Bono, P.
    Kataja, V.
    Desmedt, C.
    Piccart, M. J.
    Loibl, S.
    Denkert, C.
    Smyth, M. J.
    Joensuu, H.
    Sotiriou, C.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (08) : 1544 - 1550
  • [19] Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
    Loi, Sherene
    Sirtaine, Nicolas
    Piette, Fanny
    Salgado, Roberto
    Viale, Giuseppe
    Van Eenoo, Francoise
    Rouas, Ghizlane
    Francis, Prudence
    Crown, John P. A.
    Hitre, Erika
    de Azambuja, Evandro
    Quinaux, Emmanuel
    Di Leo, Angelo
    Michiels, Stefan
    Piccart, Martine J.
    Sotiriou, Christos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (07) : 860 - 867
  • [20] PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709